전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-3 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,016 programs
CGTLimited DatastaleEver Supreme Bio Technology Co.…Phase 2

HLA-G-CAR.BiTE allogeneic γδ T cells (HLA-G-CAR.BiTE allogeneic γδ T cells)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
AntibodyLimited DatastaleCancer Research UKPhase 2

atezolizumab (Tecentriq, HTL0039732 Capsules and atezolizumab infusion)

Neoplasms; Prostatic Neoplasms, Castration-Resistant · Neoplasms

#Neoplasms#Antibody#Phase2#monoclonal-antibody#ProstaticNeoplasms+2
Trials 1Status Recruiting
CGTLimited DatastaleFondazione Policlinico Universi…Phase 2

Haplo SCT with NK cells (Haplo SCT with NK cells)

Acute Myeloid Leukemia; Myelodysplasia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
AntibodyLimited DatastaleShuhong YiPhase 2

atezolizumab (Tecentriq, Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab)

Recurrent Liver Cancer After Liver Transplantation · Recurrent Liver Cancer After Liver Trans

#RecurrentLiverCancerAfterLiverTr#Antibody#Phase2#monoclonal-antibody#Shuhong
Trials 1Status Active
AntibodyLimited DatastaleRochePreclinical

trastuzumab (Herceptin, Herceptin (trastuzumab))

Breast Neoplasms · Breast Neoplasms

#BreastNeoplasms#Antibody#Preclinical#monoclonal-antibody#Roche
Trials 1Status Discontinued
AntibodyLimited DatastaleHunan Province Tumor HospitalPhase 2

IBI-323 combined with bevacizumab plus Platinum (IBI-323 combined with bevacizumab plus Platinum)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase2#monoclonal-antibody#Hunan
Trials 1Status Active
CGTLimited DatastaleImmune Cell, Inc.Phase 1

ICAR30 T cells (ICAR30 T cells)

Hodgkin Lymphoma; Anaplastic Large Cell Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleIkena OncologyPhase 1

nivolumab (Opdivo, IK-175 and nivolumab)

Urothelial Carcinoma; Urothelial Carcinoma Bladder · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Phase1#monoclonal-antibody#UrothelialCarcinomaBladder+1
Trials 1Status Active
CGTLimited DatastaleNational Institutes of Health C…Phase 2

IL-12 transduced TIL (IL-12 transduced TIL)

Skin Cancer; Metastatic Melanoma · MET

#MET#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
AntibodyLimited DatastaleGregory DanielsPhase 2

nivolumab (Opdivo, IL-2 and Nivolumab)

Melanoma Stage Iv; Renal Cell Carcinoma, Metastatic · Melanoma Stage Iv

#MelanomaStageIv#Antibody#Phase2#monoclonal-antibody#RenalCellCarcinoma+2
Trials 1Status Discontinued
CGTLimited DatastaleZhejiang UniversityPhase 1

IL-5 CAR-T cells (IL-5 CAR-T cells)

Hematologic Diseases; Neoplasms · Hematologic Diseases

#HematologicDiseases#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleLiping DouPhase 1

In vivo BCMA/GPRC5D Tandem Dual CAR-T cell (In vivo BCMA/GPRC5D Tandem Dual CAR-T cell)

Plasma Cell Neoplasms · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPhase 3

Induction dose of (Induction dose of, Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin)

Hepatitis C, Chronic · Hepatitis C, Chronic

#HepatitisCChronic#Antibody#Phase3#monoclonal-antibody#HepatitisC+2
Trials 1Status Active
CGTLimited DatastaleDonghua ZhangPreclinical

Infusion of BAFFR CAR-T therapy for relapsed/refractory B-cell malignancies (Infusion of BAFFR CAR-T therapy for relapsed/refractory B-cell malignancies)

Relapsed/Refractory B-cell Malignancies · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastalePfizerPhase 3

Inotuzumab (Inotuzumab)

Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#Antibody#Phase3#monoclonal-antibody#Pfizer
Trials 1Status Discontinued
ADCLimited DatastalePfizerPhase 3

INO (Inotuzumab ozogamicin, Inotuzumab ozogamicin (INO))

B-Cell Acute Lymphoblastic Leukaemia · B-Cell Acute Lymphoblastic Leukaemia

#B-CellAcuteLymphoblasticLeukaemi#ADC#Phase3#antibody-drug-conjugate#Pfizer
Trials 1Status Recruiting
AntibodyLimited DatastaleNorthwell HealthPhase 1

trastuzumab (Herceptin, Intra-arterial Cerebral Infusion of Trastuzumab)

Neoplasm Metastasis · Neoplasm Metastasis

#NeoplasmMetastasis#Antibody#Phase1#monoclonal-antibody#Northwell
Trials 1Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 2

Intra-arterial Cetuximab (Intra-arterial Cetuximab)

Glioblastoma; Anaplastic Astrocytoma · Glioblastoma

#Glioblastoma#Antibody#Phase2#monoclonal-antibody#AnaplasticAstrocytoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPhase 3

Intraarticular injection of infliximab (Intraarticular injection of infliximab)

Arthritis · Arthritis

#Arthritis#Antibody#Phase3#monoclonal-antibody#Janssen
Trials 1Status Discontinued
CGTLimited DatastaleT-MAXIMUM Pharmaceutical IncPhase 2

Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3 (Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3)

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · Glioblastoma IDH (Isocitrate Dehydrogena

#GlioblastomaIDHIsocitrateDehydro#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting

35 / 51 pages

← PreviousNext →